Core Insights - CeriBell, Inc. is participating in two upcoming investor conferences to enhance investor engagement and showcase its innovative medical technology solutions [1][2]. Group 1: Upcoming Events - CeriBell will present at the Raymond James 47 Annual Institutional Investors Conference on March 2, 2026, at 1:00 p.m. PST / 4:00 p.m. EST [2]. - The company will also participate in a fireside chat at the TD Cowen 46 Annual Health Care Conference on March 3, 2026, at 10:50 a.m. PST / 1:50 p.m. EST [2]. Group 2: Company Overview - CeriBell is focused on transforming the diagnosis and management of patients with serious neurological conditions through its innovative Ceribell System [3]. - The Ceribell System is a point-of-care electroencephalography (EEG) platform designed for acute-care settings, enabling rapid diagnosis and continuous monitoring of neurological conditions [3]. - The system is FDA-cleared for detecting seizures and delirium in intensive care units and emergency rooms across the U.S. [3].
Ceribell to Participate in Upcoming March Investor Conferences